AVDL
AVADEL PHARMACEUTICALS PLCNo price
Insider net
$0
no open-market trades · since Feb 12
New fund stakes
0
Q1 2026 13F · 1 exit
Price
Daily candles with volume.
No data for this timeframe.
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells since Feb 12. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q1 2026: 0 added (0 new), 1 trimmed or exited.
Who's buying
13F· Q1 20260
new positions
1
exit
| Fund | Move | Value |
|---|---|---|
| Neuberger Berman Group LLC | EXIT | $0.00 |
| Neuberger Berman Group LLC | ADD | $5.3M |
| FMR LLC | ADD | $1.7M |
| FMR LLC | DOUBLED | $1.5M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action Nov 2025Recent actions
| Date | Firm | Rating |
|---|---|---|
| Nov 20, 2025 | Wells Fargo MAINTAIN | Equal-Weight |
| Nov 7, 2025 | Wells Fargo MAINTAIN | Equal-Weight |
| Oct 28, 2025 | UBS DOWNGRADE | Neutral |
| Oct 23, 2025 | Leerink Partners DOWNGRADE | Market Perform |
| Oct 23, 2025 | HC Wainwright & Co. DOWNGRADE | Neutral |
| Oct 22, 2025 | Jefferies DOWNGRADE | Hold |
Insider ledger
Form 4$0
open-market buys or sells · since Feb 12
| Insider | Type | Value |
|---|---|---|
Ende Eric J Director Feb 12, 2026 | TO ISSUER | 33,000 sh |
Divis Gregory J Chief Executive Officer Feb 12, 2026 | TO ISSUER | 150,000 sh |
Divis Gregory J Chief Executive Officer Feb 12, 2026 | TO ISSUER | $4.4M |
Ende Eric J Director Feb 12, 2026 | TO ISSUER | 8,057 sh |
Ende Eric J Director Feb 12, 2026 | TO ISSUER | $4.6M |
McCamish Mark Anthony Director Feb 12, 2026 | TO ISSUER | 60,000 sh |
McCamish Mark Anthony Director Feb 12, 2026 | TO ISSUER | $462.0K |
Amin Naseem Director Feb 12, 2026 | TO ISSUER | 49,500 sh |
Washington
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Aug 5, 2026 Earnings calendar
AVDL Q2 2026 Earnings Scheduled, 2026-08-05
Mar 31, 2026 Inst.
Neuberger Berman Group LLC · EXIT
0 shares ($0.00)
Feb 12, 2026 Insider
Ende Eric J disposed of 33,000 shares
Director
Feb 12, 2026 Insider
Divis Gregory J disposed of 150,000 shares
Chief Executive Officer
Feb 12, 2026 Insider
Divis Gregory J disposed of 211,105 shares
Chief Executive Officer @ $21.00 ($4.4M)
Mar 31, 2025 Inst.
Neuberger Berman Group LLC · ADD
676,632 shares ($5.3M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 5, 2026
Earnings date
AVDL Q2 2026 Earnings Scheduled, 2026-08-05
Jun 10, 2026
Trial readout
Results Pending: FT218 (Phase 3), Completed 78d ago
Trial: Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ) Sponsor: Avadel Phase: Phase 3 | Completed: 2026-03-25 Conditions…
May 11, 2026
Trial readout
Results Pending: FT218 (Phase 3), Completed 47d ago
Trial: Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ) Sponsor: Avadel Phase: Phase 3 | Completed: 2026-03-25 Conditions…
May 5, 2026
Earnings date
AVDL Q1 2026 Earnings Scheduled, 2026-05-05
Mar 9, 2026
Earnings date
AVDL Q4 2025 Earnings After Market Close, 2026-03-09